|
Contents
|
|
|
|
Cancer
Research |
|
|
|
Bokemeyer
C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H,
Lentzen H
Silibinin
protects against cisplatin-induced nephrotoxicity without compromising
cisplatin or ifosfamide anti-tumour activity
Br J Cancer. 1996 Dec;74(12):2036-41
|
|
Jiang
C, Agarwal R, Lu J
Anti-angiogenic
potential of a cancer chemopreventive flavonoid antioxidant, silymarin:
inhibition of key attributes of vascular endothelial cells and
angiogenic cytokine secretion by cancer epithelial cells
Biochem Biophys Res Commun. 2000 Sep 16;276(1):371-8
|
|
Scambia G, De Vincenzo R, Ranelletti
FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli
E,
Mancuso S
Antiproliferative
effect of silybin on gynaecological malignancies: synergism with
cisplatin and doxorubicin
Eur J Cancer. 1996
May;32A(5):877-82
|
|
Singh
RP, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C, Agarwal R
Dietary
feeding of silibinin inhibits advanced human prostate carcinoma growth
in athymic nude mice and increases plasma insulin-like growth
factor-binding protein-3 levels
Cancer Res. 2002 Jun 1;62(11):3063-9
|
|
|
|
